Edition:
United States

Rebecca Spalding

SoftBank-backed Vir Biotechnology raises $143 million in U.S. IPO

Oct 10 2019

NEW YORK Vir Biotechnology priced its initial public offering (IPO) at $20 a share on Thursday, at the bottom end of expectations, the latest underwhelming investment performance for a stock held by SoftBank Group Corp's Vision Fund.

Germany's BioNTech raises $150 million in smaller-than-planned U.S. IPO amid market volatility

Oct 10 2019

German biotechnology firm BioNTech SE raised $150 million in its U.S. initial public offering (IPO) on Thursday, after selling fewer shares and at a lower price than originally planned, the latest company to struggle to debut in the stock market

REFILE-Germany's BioNTech lowers price for U.S. IPO amid market volatility

Oct 09 2019

Oct 9 German biotechnology firm BioNTech SE lowered the price range for its U.S. initial public offering (IPO) on Wednesday and said it would sell fewer shares, making it the latest company to struggle to debut in the stock market.

Ginkgo Bioworks raises $350 million fund for biotech spinouts

Oct 09 2019

Biotechnology start-up Ginkgo Bioworks said on Wednesday that it had raised a $350 million fund to more easily invest in spinout ventures that use its bio-engineering technology in a variety of industries that are just starting to use cutting edge biology.

Boeing-backed start-up SparkCognition raises $100 million

Oct 08 2019

SparkCognition Inc, a U.S. start-up that builds artificial intelligence technology for the industrial sectors and counts Boeing Co among its investors, said on Tuesday it raised $100 million in a new private funding round.

Credit Suisse hires Sze as sellside M&A co-head

Oct 03 2019

NEW YORK Credit Suisse Group AG has hired Stephanie Sze as a global co-head of its sellside mergers and acquisitions (M&A) group, based in New York, according to a memo seen by Reuters.

Credit Suisse hires Sze as sellside M&A co-head

Oct 03 2019

NEW YORK Credit Suisse Group AG has hired Stephanie Sze as a global co-head of its sellside mergers and acquisitions (M&A) group, based in New York, according to a memo seen by Reuters.

Biotechnology firm ADC pulls listing amid latest IPO market jitters

Oct 02 2019

Biotechnology company ADC Therapeutics SA postponed its planned $200 million U.S. initial public offering on Wednesday, citing adverse market conditions as it became the third company to pull a planned IPO in recent days.

Exclusive: Oxford Immunotec explores sale following takeover interest - sources

Sep 23 2019

Oxford Immunotec Global Plc , a medical diagnostics company that develops tests to identify tuberculosis, is exploring strategic alternatives, including a potential sale, people familiar with the matter said on Monday.

World News